Isto Holdings, the parent company of St. Louis-based Isto Biologics has acquired Progenicare, a national medical sales and service company. As a leader in bone regeneration and cell-based therapies, Isto […]Read More
Isto Biologics’ Chief Scientific Officer Presented as Faculty Speaker at the Chicago Lower Extremity Surgical Symposium
Isto’s Chief Scientific Officer, H. Davis Adkisson, Ph.D., recently spoke at The 10th Annual Chicago Lower Extremity Surgical Symposium (CLESS) as an esteemed faculty member. Dr. Adkisson presented clinical efficacy […]Read More
ISTO Technologies Sponsors the Pediatric Orthopedic Project’s 5th Medical Mission Trip to the Dominican Republic
ISTO Technologies, Inc., a privately-held orthobiologic regenerative medicine company, is honored to support the mission of the Pediatric Orthopedic Project (POP) to treat needy children in the Dominican Republic. The […]Read More
Visit ISTO at Booth #1271 during the North American Spine Society Annual Meeting in Chicago, October 14-16th. Learn more about our newest product, CellPoint Concentrated Bone Marrow Aspirate System, and […]Read More
ISTO to exhibit at the North American Spine Society (NASS) Annual Meeting featuring its newest product, CellPoint™ Concentrated Bone Marrow Aspirate System.
ISTO Technologies will feature its newest product, CellPoint Concentrated Bone Marrow Aspirate System, at the NASS 2015 Annual Meeting in Chicago.Read More